Answers are grounded in this paper and cite their sources.
This MR study demonstrates that genetically driven RC increases the risk of several CMD and cardiometabolic risk factors, suggesting that targeted RC-lowering therapies may be effective for the primary prevention of CMD.
No takes yet. Share an insight, caveat, or question.
Guan et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: